Edgewise Therapeutics grants inducement equity awards covering 31,501 shares to new hires

• Edgewise Therapeutics granted inducement equity awards to four new non-executive employees on Aug. 31, 2026.
• Stock options cover 21,000 shares with an exercise price of $41.77 per share, matching the closing price on the grant date.
• Options vest 25% on the first anniversary of each employee’s start date, then 1/48 monthly, subject to continued service.
• Restricted stock units cover 10,501 shares, vesting in four equal annual installments from the grant date, subject to continued service.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edgewise Therapeutics Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609020800PR_NEWS_USPR_____LA37760) on September 02, 2026, and is solely responsible for the information contained therein.